Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1142820200040020061
Bio, Ethics and Policy
2020 Volume.4 No. 2 p.61 ~ p.89
Social diffusion of Biomedical ethics Discussion in France: COVID-19 and the French National Consultative Ethics Committee for Health and Life Sciences
Joe Te-Gu

Min You-Ki
Abstract
The emergence of in-vitro fertilization of babies in 1982 in France raised the social debate about biomedical ethics. Accordingly, The French National Consultative Ethics Committee for Health and Life Sciences (CCNE) was established in 1983. The main task of the committee is to provide a guide to the ethical issues arising from the advancement of biotechnology. This paper analyzes the continuity and the changes in the discussions of medical bioethics by reviewing CCNE¡¯s responding activities in the context of public health crises caused by the COVID-19 pandemic. Since its inception, CCNE-related laws have continuously strengthened the independence and prominence of the committee. CCNE¡¯s 2009 document emphasized the principles of accountability, communication, and social and international solidarity during a pandemic. The 2020 documents released during the COVID-19 crisis further embody these principles and focus on the issue of supporting the vulnerable, including the elderly. CCNE has also made it possible to quickly establish advisory organizations to support medical staff facing ethical dilemmas relating to medical resource distribution and patient selection. In response to COVID-19, discussions of medical bioethics are expanding beyond the medical and scientific fields to everyday life.
KEYWORD
biomedical ethics, COVID-19, pandemic, public health crisis, French National Consultative Ethics Committee for Health and life Sciences(CCNE), medical humanities
FullTexts / Linksout information
Listed journal information